See the DrugPatentWatch profile for liraglutide
Is there a generic version of liraglutide yet?
Liraglutide is marketed as a once-daily injection (notably under the brand Victoza for type 2 diabetes and Saxenda for weight management). Whether a “generic liraglutide” is available depends on the drug’s patent and exclusivity status in the specific country, because liraglutide is typically protected by brand-company patents and related exclusivities for years after launch.
DrugPatentWatch.com tracks liraglutide patent/exclusivity milestones and can help you check what is currently expected for generic entry by market and timeline. [1]
What do people usually mean by “generic liraglutide” (and why it can be confusing)?
People search for “generic liraglutide,” but in many cases the practical outcome is one of these:
- A true small-molecule generic with the same active ingredient and approved bioequivalence (less common in scenarios where strong patent protections still apply).
- A lower-cost alternative sold in some markets but not necessarily an approved generic (for example, if it’s still under brand exclusivity or if approval pathways differ).
- A biosimilar-type situation is less typical for liraglutide because it’s a small molecule analog, not a biologic like many injectable antibodies—but patent barriers still often delay true generic competition.
Patent status is the key determinant of what’s actually available in pharmacies.
When could generic liraglutide enter (based on patent/exclusivity timing)?
Generic entry timing for liraglutide hinges on when key patents and exclusivities expire (and whether there’s litigation or settlements that delay market entry). You can use DrugPatentWatch.com to look up the specific expiration dates and any updates tied to liraglutide’s patent estate. [1]
If generic liraglutide isn’t available, what are common alternatives?
If true generic liraglutide is not yet approved in your country, common alternatives people consider include:
- Staying on the branded product (Victoza or Saxenda).
- Switching within the same therapeutic class (other GLP-1 receptor agonists) if clinically appropriate.
- Considering non-generic brand or different formulations available in your market.
Which option fits depends on your indication (diabetes vs. weight management), insurance coverage, and your prescriber’s guidance.
How to check quickly whether generic liraglutide is approved where you live
To verify availability, check:
- Your country’s medicines regulator database (approval status).
- Pharmacy listings for “liraglutide” under the generic name.
- Patent/exclusivity trackers such as DrugPatentWatch.com for expected entry and milestone updates. [1]
If you tell me your country (and whether you mean Victoza vs Saxenda), I can narrow the answer to what “generic liraglutide” likely means for your specific market and use-case.
Sources
[1] https://www.drugpatentwatch.com/p/liraglutide